Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Pneumococcal disease
NITAG documentation
Risk group
Clear all
Type of publications
NITAG documentation
(6)
Topics
Background paper
(2)
Recommendation
(4)
Available to download in languages
English (EN)
(2)
French (FR)
(2)
Spanish (ES)
(1)
Regions
Americas
(3)
Europe
(3)
Countries
Diseases
COVID-19
(5)
Pneumococcal disease
(1)
Herpes zoster
(1)
Vaccine topics
Target population
Risk group
(6)
Adults
(7)
Children
(13)
Healthcare workers
(4)
Newborn
(4)
Publication date
2022
(1)
2021
(2)
2020
(3)
6 results found
2022
∙
Conseil Supérieur de la Santé (CSS)
Vaccination against pneumococcal disease for adults in Belgium
2021
∙
JCVI
New COVID-19 vaccine advice for adults living with adults who are immunosuppressed
2021
∙
Haute Autorité de Santé
Update of risk factors for severe forms of Covid-19 and recommendations on the strategy for prioritizing populations to be vaccinated
2020
∙
CAVEI
CAVEI provisional recommendation for the initial prioritization of groups to be vaccinated against SARS-CoV-2 in the context of limited supply
2020
∙
ACIP
COVID-19 vaccine prioritization: Work Group considerations
2020
∙
ACIP, Nancy McClung
Epidemiology of Individuals at Increased Risk of COVID-19 Disease
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register